Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    " August 01, 2012":" August 31, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 01, 2012":" August 31, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Antiretroviral Therapy Adherence and Secondary Prevention of Human Immunodeficiency Virus
Condition: HIV
Interventions: Drug: antiretroviral therapy;   Behavioral: cell phone reminders;   Behavioral: contingency management for adherence
2 Completed Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique
Conditions: Anemia;   Fever;   HIV Positive
Intervention:
3 Completed Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
Condition: HIV Infection
Intervention: Procedure: colonoscopy with endoscopic biopsies
4 Suspended Pilot Study of Diflunisal in HIV-infected Adults
Condition: HIV Infection
Intervention: Drug: Diflunisal
5 Unknown  HIV Indicator Diseases Across Europe Study
Condition: HIV
Intervention:
6 Completed Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
Condition: HIV Dementia
Intervention: Drug: Ferumoxytol
7 Completed Body Image in Youth With HIV
Conditions: Human Immunodeficiency Virus;   HIV
Intervention: Other: Questionnaire
8 Completed Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
Conditions: HIV Infection;   Adverse Drug Reaction;   Quality of Life
Intervention: Drug: Raltegravir switch
9 Recruiting Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection
Condition: Human Immunodeficiency Virus
Interventions: Drug: TwHF;   Drug: placebo treatment
10 Completed Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program
Condition: Human Immunodeficiency Virus Infection
Intervention:
11 Completed Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)
Conditions: Human Immunodeficiency Virus;   Immune Reconstitution Inflammatory Syndrome
Interventions: Other: Urgent ART;   Other: Early ART
12 Completed Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel
Condition: HIV
Interventions: Drug: Oral FTC/TDF (Daily Emtricitabine/Tenofovir Disoproxil fumarate Tablet);   Drug: Rectal Daily TFV RG 1% gel (Rectally applied Tenofovir Reduced Glycerin 1% Gel);   Drug: Rectal RAI-associated TFV RG 1% gel (Receptive Anal Intercourse Associated rectally applied Tenofovir Reduced Glycerin 1% Gel)
13 Completed ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment
Condition: HIV
Intervention: Other: Tenofovir Dose Adjustment
14 Terminated ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
Conditions: HIV;   Atherosclerosis
Interventions: Drug: niacin/laropiprant;   Drug: Placebo
15 Completed Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study
Conditions: Osteoporosis;   Fractures;   HIV Infection
Intervention:
16 Active, not recruiting An Interactive Game for HIV Prevention in Early Adolescents
Conditions: HIV;   Risk Reduction
Interventions: Behavioral: Experimental Video Game;   Behavioral: Off the Shelf Video Game
17 Unknown  Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 Infection
Condition: AIDS/HIV PROBLEM
Interventions: Drug: RAL+TDF+LPV/r;   Drug: 3TC+TDF+LPV/r
18 Unknown  Efficacy and Safety of Tenofovir Plus Lamivudine Plus Efavirenz Regimen as First-line Antiretroviral Therapy
Condition: AIDS/HIV PROBLEM
Intervention: Drug: TDF+3TC+EFV
19 Completed Study to Evaluate Safety and Efficacy of UB-421 Antibody in HIV-1 Infected Adults
Condition: HIV-1 Infection in Adults
Intervention: Drug: Antibody UB-421
20 Unknown  HIV Reverse Cholesterol Transport Study
Conditions: HIV;   Dyslipidemia
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.